Swiss National Bank Enanta Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$20.68 - $39.85 $12,408 - $23,910	600 Added 1.41%	43,200 $924,000
Q1 2023 May 10, 2023	SELL	$38.82 - $54.59 $190,218 - $267,491	-4,900 Reduced 10.32%	42,600 $1.72 Million
Q4 2022 Feb 08, 2023	BUY	$40.77 - $53.73 $32,616 - $42,984	800 Added 1.71%	47,500 $2.21 Million
Q3 2022 Nov 09, 2022	BUY	$48.29 - $71.27 $33,803 - $49,889	700 Added 1.52%	46,700 $2.42 Million
Q2 2022 Aug 09, 2022	BUY	$38.13 - $76.93 $102,951 - $207,711	2,700 Added 6.24%	46,000 $2.17 Million
Q1 2022 May 09, 2022	BUY	$56.06 - $74.11 $184,998 - $244,563	3,300 Added 8.25%	43,300 $3.08 Million
Q2 2021 Aug 06, 2021	BUY	$43.76 - $53.11 $43,760 - $53,110	1,000 Added 2.56%	40,000 $1.76 Million
Q1 2021 May 07, 2021	BUY	$41.69 - $54.95 $20,845 - $27,475	500 Added 1.3%	39,000 $1.92 Million
Q3 2020 Nov 09, 2020	BUY	$43.36 - $53.53 $30,352 - $37,471	700 Added 1.85%	38,500 $1.76 Million
Q2 2020 Aug 05, 2020	BUY	$46.37 - $57.58 $421,967 - $523,978	9,100 Added 31.71%	37,800 $1.9 Million
Q1 2020 May 08, 2020	BUY	$40.22 - $62.0 $16,088 - $24,800	400 Added 1.41%	28,700 $1.48 Million
Q4 2019 Feb 06, 2020	BUY	$57.95 - $66.61 $34,770 - $39,966	600 Added 2.17%	28,300 $1.75 Million
Q3 2019 Nov 12, 2019	BUY	$60.08 - $88.17 $36,048 - $52,902	600 Added 2.21%	27,700 $1.66 Million
Q2 2019 Aug 02, 2019	BUY	$81.3 - $97.35 $48,780 - $58,410	600 Added 2.26%	27,100 $2.29 Million
Q1 2019 May 10, 2019	BUY	$69.08 - $105.66 $55,264 - $84,528	800 Added 3.11%	26,500 $2.53 Million
Q4 2018 Feb 13, 2019	BUY	$65.41 - $84.65 $45,787 - $59,255	700 Added 2.8%	25,700 $1.82 Million
Q1 2018 May 04, 2018	BUY	$57.91 - $92.15 $86,865 - $138,225	1,500 Added 6.38%	25,000 $2.02 Million
Q3 2017 Nov 03, 2017	BUY	$37.91 - $46.8 $890,884 - $1.1 Million	23,500	23,500 $1.1 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$18 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$17 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$15.8 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$12.8 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$9.44 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account